Hill-Rom upgraded to Conviction Buy from Buy at Goldman Goldman upgraded Hill-Rom based on expectations for a turn in the hospital bed cycle. Price target raised to $41 from $40.
News For HRC From The Last 14 Days
Check below for free stories on HRC the last two weeks.